Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

197.54 -1.26 (-0.63%)
Official Closing Price Updated: 4:10 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Danaher would probably like to forget the past six months even happened. The stock dropped 23.9% and now trades at $207. This might have investors contemplating their next move. 
Via StockStory
Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst... 
Via StockStory
Topics Economy
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Danaher's Options Frenzy: What You Need to Know
Via Benzinga
P/E Ratio Insights for Danaher
Via Benzinga
Danaher's Options Frenzy: What You Need to Know
Via Benzinga
Danaher Unusual Options Activity For February 07
Via Benzinga
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher. 
Via Benzinga
3 Stocks Offering Strong Value and Stability
These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance. 
Via MarketBeat
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Danaher's Options: A Look at What the Big Money is Thinking
Via Benzinga
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Via Benzinga
Danaher Analysts Cut Their Forecasts After Downbeat Earnings
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Danaher Stock
Via Benzinga
Super Investors Just Bought These Stocks
Every quarter, we get to see what the best of the best have bought and sold. 
Via The Motley Fool
3 Healthcare Stocks Skating on Thin Ice
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and... 
Via StockStory
Topics Stocks
Waters Corporation Earnings: What To Look For From WAT
Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow before the bell. Here’s what to look for. 
Via StockStory
Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One'
NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025. 
Via Benzinga
Avantor Earnings: What To Look For From AVTR
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow
Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect. 
Via StockStory
This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates
Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per... 
Via StockStory
Topics Earnings
Broad-Based Sector Growth Expected For 2025
Total earnings for the 112 S&P 500 companies that have reported results are up +10.8% from the same period last year on +5.5% higher revenues, with 80.4% beating EPS estimates and 68.8% beating revenue... 
Via Talk Markets
Topics Stocks Stocks / Equities
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Wednesday's pre-market session: top gainers and losers in the S&P500 index
Pre-market stock analysis of S&P500 stocks on 2025-01-29: top gainers and losers in today's session. 
Via Chartmill
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
Caution dominates Wednesday's midday trading session in New York as investors anxiously await the Federal Open Market Committee decision at 2 p.m. ET. 
Via Benzinga
Topics Economy Government
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.